Peers of Neurosense Therapeutics Ltd (NRSN)
Side-by-side comparison
Free AI scores & summaries library
Health Care · Biotechnology
Enterprise value divided by free cash flow over the last 12 months. Values the whole business on the cash it generates.
Latest EV/FCF
-0.82x
As of Oct 19, 2026
Beyond EV/FCF, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/FCF |
|---|---|
| Oct 19, 2026 | -0.82x |
| Oct 16, 2026 | -0.94x |
| Oct 15, 2026 | -0.97x |
| Oct 14, 2026 | -0.94x |
| Oct 13, 2026 | -1.07x |
| Oct 12, 2026 | -1.06x |
| Oct 9, 2026 | -1.12x |
| Oct 8, 2026 | -1.09x |
EV/FCF = Enterprise Value / Free Cash Flow (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/FCF is especially insightful for capital-intensive businesses.
Read the general EV/FCF definition, formula, and analyst usage guide.
EV/FCF guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison